NEUROFIBROMATOSIS 1

Clinical trials for NEUROFIBROMATOSIS 1 explained in plain language.

Never miss a new study

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 8 Completed 4

New drug duo tested to fight disfiguring tumors

Disease control Not yet recruiting

This early-stage study is testing whether combining two existing cancer drugs, cabozantinib and selumetinib, is safe and effective for shrinking painful and disfiguring tumors (plexiform neurofibromas) in people aged 16 and older with neurofibromatosis type 1 (NF1). The research …

Matched conditions: NEUROFIBROMATOSIS 1

Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control

Last updated Apr 01, 2026 14:53 UTC

NEUROFIBROMATOSIS 1

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

New drug duo tested to fight disfiguring tumors